Published online Aug 16, 2022. doi: 10.12998/wjcc.v10.i23.8115
Peer-review started: December 11, 2021
First decision: January 10, 2022
Revised: January 21, 2022
Accepted: July 16, 2022
Article in press: July 16, 2022
Published online: August 16, 2022
Processing time: 232 Days and 21.5 Hours
Intestinal bladder augmentation is widely used for neurogenic bladder with good results and is standard cystoplasty (SC). However, due to the mucous secretion and reabsorption function of the intestinal mucosa, many related complications occur. To preclude the contact of urine with gastrointestinal mucosa, alternative methods have been investigated. Seromuscular bladder augmentation (SMBA) could effectively expand the bladder capacity and avoid complications related to integrating the intestinal mucosa into the bladder.
SMBA was not widely accepted and was only reported in a few institutions. Further study is needed to evaluate the safety and effectiveness of SMBA in the treatment of neurogenic bladder.
The aim of our study was to assess the outcomes of patients undergoing SC and SMBA to evaluate the safety and effectiveness of SMBA in the treatment of patients with neurogenic bladder.
This study retrospectively analyzed the clinical data of children with SMBA and compared the data with those of children with SC completed during the same period.
No significant difference was found in the preoperative urinary dynamic parameters between the two groups, but the comparison after operation was statistically significant. The main complications after SMBA were residual ureteral reflux and failed bladder augmentation. All 6 patients with failed augmentation in the SMBA group used ileum seromuscular patches for augmentation, and SC was chosen for reaugmentation. During the reoperation, patch contracture and fibrosis were observed.
The improvement of the urodynamic parameters in the SMBA group was significantly poorer than that in the SC group. The probability of patch contracture and reaugmentation was higher, likely related to an impaired blood supply and urine irritation, and the sigmoid colon patch should be the priority.
This study was a retrospective study, and each group had different concomitant operations, which might affect the evaluation of the outcomes. Histopathological research was not performed on the shrunken patch, and collagen deposition was not observed. In the future, prospective and controlled studies are needed to support our conclusions.